Before you begin!
The FemTech Observatory Global Survey 2026 is still open, and we’re inviting you to take part.
If you’re building in women’s health, this is your chance to be counted in the first global, data-driven map of the FemTech ecosystem.
Request access here: https://tally.so/r/WOe6BQ
Deadline: June 30th
Let’s make sure our voices are in the room.
Now to today’s piece.
Ask ten FemTech founders what clinical validation means and you will get ten different answers. Some will say it means running a clinical trial. Some will say it means having a doctor review their content. Some will say it means getting regulatory approval. A few will admit they are not entirely sure but know they are supposed to have it.
The confusion is understandable.
Clinical validation is one of the most frequently used and least clearly defined phrases in women’s health innovation. And because it means different things in different contexts, founders often either pursue the wrong kind at the wrong time or assume that it is too complex or too expensive to think about at their stage.
Neither of those outcomes is good. So let us start from the beginning.
Clinical validation is not one thing.
Clinical validation is an umbrella term that covers several distinct activities, each serving a different purpose and requiring a different kind of evidence.
In FemTech, clinical validation typically means one or more of the following three things, depending on who is asking and why.
Clinical credibility—evidence that your product does what it says it does, documented in a way that a clinician or any informed user would find convincing. This is the usual starting point for everything else.
Investor validation — evidence that gives an investor something concrete to point to when justifying a funding decision. This does not always require a formal clinical trial. It requires data that is honest, relevant, and clearly presented.
Regulatory validation — evidence that a regulatory body requires before you can market your product in a specific jurisdiction. This is the most formal category, and it is triggered by how your product is classified, not just by what it does.
Getting clear on which of these you actually need right now, rather than pursuing all three simultaneously, is one of the most useful things a founder can do early.
What you need depends on what you are claiming
The level of validation your product needs is directly proportional to the strength of your claims.
Different types of health products require different levels of evidence. Educational content should be clinically accurate and evidence-based, but it does not need the same validation as a diagnostic tool. A product claiming to track ovulation with a defined level of accuracy needs data to support that claim. A product suggesting a diagnosis falls into a different regulatory category and requires a substantially higher standard of evidence.
Most FemTech founders sit somewhere in the middle. The honest work is understanding exactly where your product sits and whether your evidence matches your claims.
Match your evidence to your stage
An early-stage company does not need a randomized control trial. It needs enough evidence to support the claims it is making right now.
A structured review of existing literature showing your problem is real is a legitimate starting point. A small pilot measuring engagement and self-reported outcomes is a meaningful next step. Neither is a clinical trial, but both demonstrate clinical seriousness to clinicians, users, and investors.
As the product matures and claims become more specific, the evidence strategy should evolve with it. Think of it as a roadmap, not a one-time event.
Know the difference between describing and claiming
Many founders cross the line between describing what a product does and claiming what it achieves, without realizing it.
“Our app provides evidence-based support for women navigating PMOS symptoms” describes the product. ” Our app improves hormonal health outcomes for women with PMOS” is a clinical efficacy claim that requires a study behind it.
The difference sounds subtle, but the regulatory implications are not.
Where to start
Clinical validation is not a checkbox but an ongoing commitment to ensuring that what you claim about your product is supported by evidence proportionate to that claim.
But knowing what validation means is only the beginning. The harder question, the one most founders are actually asking, is how much evidence is enough and for what kind of product.
That depends on where your product sits. And that is exactly where we go next.
Next week, we’ll look at “How Much Evidence Your FemTech Product Actually Needs.”
Better Woman Health is published weekly.
Subscribe at betterwomanhealth.com to get it directly in your inbox.
Clinical Credibility Toolkit
The Clinical Credibility Toolkit is a free resource designed for FemTech founders building digital tools for women’s health.
It includes the Clinical Credibility Scorecard, a 28-question assessment that helps you identify gaps in your clinical foundation, evidence strategy, safety architecture, and investor readiness, and the Red Flag Detection Checklist, a 25-question assessment that tells you whether your symptom-tracking app can actually detect and act on medical red flags, not just log them.
If you are preparing to pitch, pursuing healthcare partnerships, or simply want to know where your product stands clinically, start here.
Access the toolkit → app.ayomide.me
Thanks for reading. See you soon!
Dr. Ayomide O.
Clinical Strategy & African Market Advisory
Find me on LinkedIn or Book a 1:1 Call
